Extraintestinal involvement, including the chest, is common in the late course of Crohn’s disease. We describe 2 female patients in whom the course of the disease was unique in two aspects: (1) each had a pulmonary mass with granulomatous inflammation and necrosis, and (2) these findings had preceded the colonic involvement by 5 years. This sequence supports some of the theories on the pathogenesis of Crohn’s disease and on its possible relation with sarcoidosis, another idiopathic granulomatous disease.

Keywords:
Crohn’s disease, Extracolonic involvement, Inflammatory bowel disease, Sarcoidosis, Tuberculosis
1.
Storch I, Sachar D, Katz S: Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:104–115.
2.
Baughman RP, Lower EE, Du Bois RM: Sarcoidosis. Lancet 2003;361:1111–1118.
3.
Chowers Y: Interaction of genetic, environmental and immune factors in the pathogenesis of inflammatory bowel diseases. Isr Med Assoc J 2002;4:815–817.
4.
Levine J, Lukawaski-Trubish D: Extraintestinal considerations in inflammatory bowel disease. Gastroenterol Clin North Am 1995;24:633–646.
5.
Rankin GB, Watts HD, Melnyck CJ, Kelley ML Jr: National Cooperative Crohn’s Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979;77:914–920.
6.
Faller M, Gasser B, Massard G, Pauli G, Quoix E: Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn’s disease. Respiration 2000;67:459–463.
7.
Camus P, Piard F, Ashcroft T, Gal A, Colby T: The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72:151–183.
8.
Le Gall F, Loeuillet L, Delaval P, Thoreux PH, Desrues B, Ramee MP: Necrotizing sarcoid granulomatosis with and without extrapulmonary involvement. Pathol Res Pract 1996;192:306–313.
9.
Rizzato G, Tinelli C: Unusual presentation of sarcoidosis. Respiration 2005;72:3–6.
10.
Grutters JC, Sato H, Welsh KI, du Bois RM: The importance of sarcoidosis genotype to lung phenotype. Am J Respir Cell Mol Biol 2003;29:S59–S62.
11.
Ho LP, Merlin F, Gaber K, Davies RJ, McMichael AJ, Hugot JP: CARD 15 mutations in sarcoidosis. Thorax 2005;60:354–355.
12.
Schurmann M, Valentonyte R, Hampe J, Muller-Quernheim J, Schwinger E, Schreiber S: CARD15 gene mutations in sarcoidosis. Eur Respir J 2003;22:748–754.
13.
Kanazawa N, Okafuji I, Kambe N, Nishikomori R, et al: Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-κB activation: common genetic etiology with Blau syndrome. Blood 2005;105:1195–1197.
14.
Bombieri C, Luisetti M, Belpinati F, Zuliani E, et al: Increased frequency of CFTR gene mutations in sarcoidosis: a case/control association study. Eur J Hum Genet 2000;8:717–720.
15.
Schurmann M, Albrecht M, Schwinger E, Stuhrmann M: CFTR gene mutations in sarcoidosis. Eur J Hum Genet 2002;10:729–732.
16.
Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG: Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 2001;357:1925–1928.
17.
Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A, Nagy M, Gaede KI, Franke A, Haesler R, Koch A, Lengauer T, Seegert D, Reiling N, Ehlers S, Schwinger E, Platzer M, Krawczak M, Muller-Quernheim J, Schurmann M, Schreiber S: Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005;37:357–364.
18.
Zhou Y, Yamaguchi E, Hizawa N, Nishimura M: Roles of functional polymorphisms in the interleukin-18 gene promoter in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:105–113.
19.
Amoli MM, Donn RP, Thomson W, Hajeer AH, Garcia-Porrua C, Lueiro M, et al: Macrophage migration inhibitory factor gene polymorphism is associated with Sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 2002;29:1671–1673.
20.
Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, Pandey JP, Newman LS, Magira E, Beznik-Cizman B, Monos D; ACCESS Group: HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003;73:729–735.
21.
Handa T, Nagai S, Ito I, Tabuena R, Shigematsu M, Hamada K, Kitaichi M, Izumi T, Aoyama T, Toguchida J, Mishima M: Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration 2005;72:243–248.
22.
Travis W, Colby T, Koss M, Rosado-de-Christenson ML, Muller N, King T Jr: Non-Neoplastic Disorders of the Lower Respiratory Tract. Washington, American Registry of Pathology and Armed Forces Institute of Pathology, 2002.
23.
Ikonomopoulos JA, Gorgoulis VG, Kastrinakis NG, Zacharatos PV, Kokotas SN, Evangelou K, Kotsinas AG, Tsakris AG, Manolis EN, Kittas CN: Sensitive differential detection of genetically related mycobacterial pathogens in archival material. Am J Clin Pathol 2000;114:940–950.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.